Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tango Therapeutics, Inc. (TNGX)
USD28.36
-2.70 (-8.69%)
US NASDAQ Healthcare Biotechnology
Address
100 Binney Street 2142
Boston, MA, US
Boston, MA, US
CEO
Malte Peters
Website
tangotx.com
IPO
2020-09-03
CIK 1819133 ISIN US87583X1090
Description
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| BCTG Acquisition Corp. | BCTG | 2021-04-19 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD28.36
-2.70 (-8.69%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
1.13
Float Shares
76.57M
Free Float %
65.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.55% | +7.59% | +18.32% | +97.75% | +230.44% | +187.92% | +1,722.14% | +576.66% | +125.75% | +149.36% | +149.36% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Buy
Price Targets & DCF
Current price
28.36
Low
14.00
-50.6%
Consensus
22.75
-19.8%
Median
18.50
-34.8%
High
40.00
+41.0%
Ratings Trend (MoM)
92% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 10 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
40.00
+41.0%
|
| Last Quarter | 4 |
25.25
-11.0%
|
| Last Year | 7 |
20.29
-28.5%
|
| All Time | 10 |
18.60
-34.4%
|
Quality scores
Altman Z-Score
38.38
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+48.3% ★ Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+26.9% Q1'26: +11.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-284.1%
-
EBIT margin Biotechnology: +0.0%-178.4%
-
ROIC Biotechnology: -16.1%-304.0% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+6.4% Q1'26: +30.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.31× Q1'26: -0.17× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 10 EPS Ana. |
Dec 2027 7 Rev. Ana. 8 EPS Ana. |
Dec 2028 9 Rev. Ana. 8 EPS Ana. |
Dec 2029 4 Rev. Ana. 6 EPS Ana. |
Dec 2030 4 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
37.04M
est: 37.91M (-2.3%)
|
24.86M
est: 24.78M (+0.3%)
|
36.53M
est: 42.51M (-14.1%)
|
42.07M
est: 46.01M (-8.6%)
|
62.38M
est: 62.81M (-0.7%)
|
6.06M
6.06M – 6.06M
-90.4% YoY
|
3.93M
3.93M – 3.93M
-35.2% YoY
|
49.03M
49.03M – 49.03M
+1,148.9% YoY
|
207.92M
207.92M – 207.92M
+324.1% YoY
|
568.17M
568.17M – 568.17M
+173.3% YoY
|
| EBITDA |
-57.29M
est: -37.91M (-51.1%)
|
-109.46M
est: -24.78M (-341.7%)
|
-111.76M
est: -42.51M (-162.9%)
|
-143.10M
est: -46.01M (-211.0%)
|
-109.01M
est: -62.81M (-73.5%)
|
-6.06M
-6.06M – -6.06M
+90.4% YoY
|
-3.93M
-3.93M – -3.93M
+35.2% YoY
|
-49.03M
-49.03M – -49.03M
-1,148.9% YoY
|
-207.92M
-207.92M – -207.92M
-324.1% YoY
|
-568.17M
-568.17M – -568.17M
-173.3% YoY
|
| EBIT |
-58.19M
est: -37.91M (-53.5%)
|
-111.07M
est: -24.78M (-348.2%)
|
-114.17M
est: -42.51M (-168.6%)
|
-145.60M
est: -46.01M (-216.5%)
|
-111.29M
est: -62.81M (-77.2%)
|
-6.06M
-6.06M – -6.06M
+90.4% YoY
|
-3.93M
-3.93M – -3.93M
+35.2% YoY
|
-49.03M
-49.03M – -49.03M
-1,148.9% YoY
|
-207.92M
-207.92M – -207.92M
-324.1% YoY
|
-568.17M
-568.17M – -568.17M
-173.3% YoY
|
| Net Income |
-58.24M
est: -113.16M (+48.5%)
|
-108.18M
est: -141.83M (+23.7%)
|
-101.74M
est: -129.15M (+21.2%)
|
-130.30M
est: -145.57M (+10.5%)
|
-101.59M
est: -101.59M (+0.0%)
|
-161.14M
-185.31M – -136.97M
-58.6% YoY
|
-181.12M
-223.67M – -138.57M
-12.4% YoY
|
-264.45M
-284.44M – -124.37M
-46.0% YoY
|
-142.50M
-142.50M – -142.50M
+46.1% YoY
|
87.32M
87.32M – 87.32M
+161.3% YoY
|
| SGA |
17.60M
est: 36.18M (-51.4%)
|
30.03M
est: 23.64M (+27.0%)
|
35.50M
est: 37.07M (-4.2%)
|
43.75M
est: 40.12M (+9.0%)
|
41.51M
est: 54.77M (-24.2%)
|
5.28M
5.28M – 5.28M
-90.4% YoY
|
3.42M
3.42M – 3.42M
-35.2% YoY
|
42.75M
42.75M – 42.75M
+1,148.9% YoY
|
181.30M
181.30M – 181.30M
+324.1% YoY
|
495.44M
495.44M – 495.44M
+173.3% YoY
|
| EPS |
-0.94
est: -1.04 (+9.3%)
|
-1.23
est: -1.26 (+2.1%)
|
-1.08
est: -1.11 (+2.9%)
|
-1.19
est: -1.20 (+0.9%)
|
-0.87
est: -0.87 (+0.2%)
|
-1.34
-1.60 – -1.18
-53.4% YoY
|
-1.60
-1.93 – -1.19
-19.7% YoY
|
-1.71
-2.45 – -1.07
-6.8% YoY
|
-1.23
-1.23 – -1.23
+28.3% YoY
|
0.75
0.75 – 0.75
+161.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-27 | Stifel | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-126.86M
OE per share TTM
-1.03
Owner's Yield
-4.28%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
98.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
74
Total invested
430.07M
Insider transactions (90d)
3
Beneficial owners (>5%)
36
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 19.36M | 22.10% | — | 19.36M | — | 19.36M | OO | — | 2021-08-19 | ↗ |
| 2 | Third Rock Ventures GP IV, L.P. | 19.36M | 22.10% | — | 19.36M | — | 19.36M | PN | — | 2021-08-19 | ↗ |
| 3 | Third Rock Ventures IV, L.P. | 19.36M | 22.10% | — | 19.36M | — | 19.36M | PN | — | 2021-08-19 | ↗ |
| 4 | Chen Yu | 10.50M | 9.80% | — | 10.50M | — | 10.50M | IN | Delaware | 2024-11-20 | ↗ |
| 5 | TCG Crossover Fund II, L.P. | 10.50M | 9.80% | — | 10.50M | — | 10.50M | PN | Delaware | 2024-11-20 | ↗ |
| 6 | TCG Crossover GP II, LLC | 10.50M | 9.80% | — | 10.50M | — | 10.50M | OO | Delaware | 2024-11-20 | ↗ |
| 7 | EcoR1 Capital, LLC | 7.83M | 11.00% | — | 7.83M | — | 7.83M | IA, OO | Delaware | 2023-09-21 | ↗ |
| 8 | Oleg Nodelman | 7.83M | 11.00% | — | 7.83M | — | 7.83M | HC, IN | Delaware | 2023-09-21 | ↗ |
| 9 | EcoR1 Capital Fund Qualified, L.P. | 7.37M | 11.00% | — | — | 7.37M | 7.37M | PN | Delaware | 2023-09-21 | ↗ |
| 10 | FMR LLC | 7.18M | 6.59% | 1.07M | — | 7.18M | — | HC | Delaware | 2022-02-09 | ↗ |
| 11 | BCTG Holdings, LLC | 6.99M | 8.30% | 6.99M | — | 6.99M | — | OO | — | 2021-08-20 | ↗ |
| 12 | Boxer Asset Management Inc. | 6.87M | 8.10% | — | 6.87M | — | 6.87M | CO | — | 2021-08-20 | ↗ |
| 13 | Boxer Capital, LLC | 6.87M | 8.10% | — | 6.87M | — | 6.87M | OO | — | 2021-08-20 | ↗ |
| 14 | Joe Lewis | 6.87M | 8.10% | — | 6.87M | — | 6.87M | IN | — | 2021-08-20 | ↗ |
| 15 | Costas Constantinides | 5.53M | 5.40% | — | 5.53M | — | — | IN | Luxembourg | 2023-08-21 | ↗ |
| 16 | Ian Charoub | 5.53M | 5.40% | — | 5.53M | — | — | IN | Luxembourg | 2023-08-21 | ↗ |
| 17 | Nextech Crossover I GP S.à r.l. | 5.53M | 5.40% | 5.53M | — | 5.53M | — | OO | Luxembourg | 2023-08-21 | ↗ |
| 18 | Nextech Crossover I SCSp | 5.53M | 5.40% | 5.53M | — | 5.53M | — | PN | Luxembourg | 2023-08-21 | ↗ |
| 19 | Rocco Sgobbo | 5.53M | 5.40% | — | 5.53M | — | — | IN | Luxembourg | 2023-08-21 | ↗ |
| 20 | Casdin Capital, LLC | 5.49M | 6.30% | — | 5.49M | — | 5.49M | IA | Cayman Islands | 2021-08-19 | ↗ |
| 21 | Casdin Partners GP, LLC | 5.49M | 6.30% | — | 5.49M | — | 5.49M | OO | Cayman Islands | 2021-08-19 | ↗ |
| 22 | Casdin Partners Master Fund, L.P. | 5.49M | 6.30% | — | 5.49M | — | 5.49M | PN | Cayman Islands | 2021-08-19 | ↗ |
| 23 | Eli Casdin | 5.49M | 6.30% | — | 5.49M | — | 5.49M | HC, IN | Cayman Islands | 2021-08-19 | ↗ |
| 24 | Bihua Chen | 4.90M | 5.60% | — | 4.90M | — | 4.90M | HC | United States | 2022-02-14 | ↗ |
| 25 | Cormorant Asset Management, LP | 4.90M | 5.60% | — | 4.90M | — | 4.90M | IA | Delaware | 2022-02-14 | ↗ |
| 26 | Gilead Sciences, Inc. | 4.85M | 5.50% | 4.85M | — | 4.85M | — | CO | Delaware | 2021-09-10 | ↗ |
| 27 | John S. Clark II | 4.50M | 5.10% | — | 4.50M | — | 4.50M | IN | Delaware | 2022-07-11 | ↗ |
| 28 | Southpoint Capital Advisors LLC | 4.50M | 5.10% | — | 4.50M | — | 4.50M | OO | Delaware | 2022-07-11 | ↗ |
| 29 | Southpoint Capital Advisors LP | 4.50M | 5.10% | — | 4.50M | — | 4.50M | PN | Delaware | 2022-07-11 | ↗ |
| 30 | Southpoint GP, LLC | 4.50M | 5.10% | — | 4.50M | — | 4.50M | OO | Delaware | 2022-07-11 | ↗ |
| 31 | Southpoint GP, LP | 4.50M | 5.10% | — | 4.50M | — | 4.50M | PN | Delaware | 2022-07-11 | ↗ |
| 32 | Southpoint Master Fund, LP | 4.50M | 5.10% | — | 4.50M | — | 4.50M | PN | Delaware | 2022-07-11 | ↗ |
| 33 | 2 | 1.91M | 8.90% | — | 1.91M | — | 1.91M | PN | Cayman Islands | 2021-04-26 | ↗ |
| 34 | RA Capital Management, L.P. | 1.25M | 5.80% | — | 1.25M | — | 1.25M | IA, PN | United States of America | 2021-02-16 | ↗ |
| 35 | Aaron I. Davis | 101.5K | 0.10% | — | 101.5K | — | 101.5K | IN | — | 2021-08-20 | ↗ |
| 36 | MVA Investors, LLC | 101.5K | 0.10% | — | 101.5K | — | 101.5K | OO | — | 2021-08-20 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
74
-97 vs prev Q
New positions
20
Closed positions
115
Increased
46
Reduced
19
Put/Call ratio
0.00
Calls held
—
Puts held
32.8K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MASS GENERAL BRIGHAM, INC | 354.2K +354.2K (+100.0%) | 3.14B +3.1B (+100.0%) | 0.32% +0.319 pp | 0.39% +0.388 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 2 | FARALLON CAPITAL MANAGEMENT LLC | 13.06M +2.3M (+21.4%) | 115.72M +25.4M (+28.1%) | 11.77% +2.039 pp | 0.55% +0.176 pp | USD5.38 +64.7% | 5 qtrs — |
| 3 | TCG CROSSOVER MANAGEMENT, LLC | 12.76M +4.2M (+49.5%) | 113.07M +41.4M (+57.7%) | 11.50% +3.779 pp | 3.74% +0.215 pp | USD5.00 +77.2% | 5 qtrs — |
| 4 | BOXER CAPITAL MANAGEMENT, LLC | 10.88M +1.1M (+11.3%) | 96.36M +14.3M (+17.4%) | 9.80% +0.962 pp | 21.09% -5.071 pp | USD3.68 +140.8% | 5 qtrs — |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 10.61M +8.1M (+322.5%) | 93.99M +72.9M (+345.6%) | 9.56% +7.288 pp | 0.14% +0.109 pp | USD7.97 +11.2% | 3 qtrs — |
| 6 | WOODLINE PARTNERS LP | 10.07M +4.0M (+67.0%) | 89.24M +38.6M (+76.2%) | 9.08% +3.622 pp | 0.35% +0.107 pp | USD6.50 +36.3% | 7 qtrs — |
| 7 | BLACKROCK, INC. | 8.54M +2.9M (+51.2%) | 75.67M +28.2M (+59.5%) | 7.70% +2.588 pp | 0.00% +0.000 pp | USD7.67 +15.5% | 6 qtrs — |
| 8 | SIREN, L.L.C. | 8.17M +2.3M (+38.8%) | 72.35M +22.9M (+46.4%) | 7.36% +2.036 pp | 2.16% +0.225 pp | USD7.99 +10.9% | 6 qtrs — |
| 9 | TRV GP IV, LLC | 7.87M -6.0M (-43.2%) | 69.77M -46.7M (-40.1%) | 7.10% -5.446 pp | 27.35% -15.163 pp | USD12.93 -31.5% | 18 qtrs — |
| 10 | NEXTECH INVEST, LTD. | 7.27M +1.7M (+31.3%) | 64.38M +17.9M (+38.5%) | 6.55% +1.542 pp | 6.22% -0.852 pp | USD3.16 +180.4% | 4 qtrs — |
| 11 | VANGUARD GROUP INC | 6.75M +1.7M (+33.6%) | 59.81M +17.4M (+40.9%) | 6.08% +1.514 pp | 0.00% +0.000 pp | USD8.73 +1.5% | 18 qtrs — |
| 12 | STATE STREET CORP | 6.22M +2.9M (+84.8%) | 55.10M +26.8M (+94.9%) | 5.60% +2.560 pp | 0.00% +0.001 pp | USD8.30 +6.7% | 18 qtrs — |
| 13 | BALYASNY ASSET MANAGEMENT L.P. | 5.28M +1.8M (+52.0%) | 46.77M +17.6M (+60.3%) | 4.76% +1.616 pp | 0.06% +0.022 pp | USD7.67 +15.5% | 7 qtrs — |
| 14 | GOLDMAN SACHS GROUP INC | 4.94M +3.4M (+227.4%) | 43.79M +31.1M (+245.4%) | 4.45% +3.088 pp | 0.01% +0.004 pp | USD8.72 +1.6% | 17 qtrs — |
| 15 | LOGOS GLOBAL MANAGEMENT LP | 4.20M +3.3M (+342.1%) | 37.21M +29.2M (+366.3%) | 3.78% +2.926 pp | 2.25% +1.533 pp | USD8.76 +1.1% | 2 qtrs — |
| 16 | BELLEVUE GROUP AG | 3.93M +3.9M (+100.0%) | 34.80M +34.8M (+100.0%) | 3.54% +3.540 pp | 0.66% +0.660 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 17 | CALIGAN PARTNERS LP | 3.73M +3.7M (+100.0%) | 33.05M +33.0M (+100.0%) | 3.36% +3.361 pp | 2.72% +2.720 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 18 | NANTAHALA CAPITAL MANAGEMENT, LLC | 3.57M +1.8M (+97.4%) | 31.65M +16.4M (+108.2%) | 3.22% +1.582 pp | 1.05% +0.519 pp | USD6.03 +46.9% | 5 qtrs — |
| 19 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.91M +2.9M (+100.0%) | 25.76M +25.8M (+100.0%) | 2.62% +2.620 pp | 0.33% +0.329 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 20 | FMR LLC | 2.87M +2.9M (+44,524.2%) | 25.41M +25.4M (+46,968.2%) | 2.58% +2.578 pp | 0.00% +0.001 pp | USD8.86 +0.0% | 18 qtrs — |
| 21 | SUVRETTA CAPITAL MANAGEMENT, LLC | 2.66M +2.7M (+100.0%) | 23.59M +23.6M (+100.0%) | 2.40% +2.399 pp | 0.48% +0.483 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 22 | JANUS HENDERSON GROUP PLC | 2.64M +342.0K (+14.9%) | 23.47M +4.2M (+21.5%) | 2.38% +0.300 pp | 0.01% +0.002 pp | USD8.46 +4.7% | 2 qtrs — |
| 23 | GEODE CAPITAL MANAGEMENT, LLC | 2.55M +670.9K (+35.6%) | 22.63M +6.8M (+43.1%) | 2.30% +0.598 pp | 0.00% +0.000 pp | USD8.20 +8.0% | 18 qtrs — |
| 24 | DEEP TRACK CAPITAL, LP | 2.45M +1.0M (+68.7%) | 21.75M +9.5M (+78.0%) | 2.21% +0.896 pp | 0.39% +0.047 pp | USD8.59 +3.1% | 2 qtrs — |
| 25 | VIVO CAPITAL, LLC | 2.15M +1.4M (+177.4%) | 19.09M +12.6M (+192.6%) | 1.94% +1.239 pp | 1.23% +0.709 pp | USD7.78 +13.9% | 3 qtrs — |
| 26 | POINT72 ASSET MANAGEMENT, L.P. | 1.97M -945.4K (-32.4%) | 17.49M -7.0M (-28.7%) | 1.78% -0.862 pp | 0.02% -0.022 pp | USD8.40 +5.5% | 2 qtrs — |
| 27 | RTW INVESTMENTS, LP | 1.49M +1.5M (+100.0%) | 13.21M +13.2M (+100.0%) | 1.34% +1.344 pp | 0.13% +0.132 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 28 | MORGAN STANLEY | 1.42M +1.2M (+464.7%) | 12.60M +10.5M (+495.6%) | 1.28% +1.054 pp | 0.00% +0.001 pp | USD8.50 +4.2% | 18 qtrs — |
| 29 | FRANKLIN RESOURCES INC | 1.40M +471.2K (+50.8%) | 12.39M +4.6M (+59.1%) | 1.26% +0.421 pp | 0.00% +0.001 pp | USD8.16 +8.6% | 9 qtrs — |
| 30 | D. E. SHAW & CO., INC. | 1.03M +595.2K (+138.3%) | 9.09M +5.5M (+151.3%) | 0.92% +0.535 pp | 0.01% +0.003 pp | USD8.67 +2.2% | 5 qtrs — |
| 31 | AFFINITY ASSET ADVISORS, LLC | 1.00M +1.0M (+100.0%) | 8.86M +8.9M (+100.0%) | 0.90% +0.901 pp | 0.50% +0.505 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 32 | UBS GROUP AG | 990.5K +830.0K (+517.2%) | 8.78M +7.4M (+551.0%) | 0.89% +0.747 pp | 0.00% +0.001 pp | USD8.48 +4.5% | 17 qtrs — |
| 33 | BOOTHBAY FUND MANAGEMENT, LLC | 957.3K +957.3K (+100.0%) | 8.48M +8.5M (+100.0%) | 0.86% +0.863 pp | 0.13% +0.127 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 34 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 841.0K +182.7K (+27.8%) | 7.45M +1.9M (+34.7%) | 0.76% +0.162 pp | 0.00% +0.000 pp | USD8.31 +6.6% | 18 qtrs — |
| 35 | NORTHERN TRUST CORP | 803.2K +197.6K (+32.6%) | 7.12M +2.0M (+39.9%) | 0.72% +0.176 pp | 0.00% +0.000 pp | USD7.06 +25.5% | 18 qtrs — |
| 36 | CANDRIAM S.C.A. | 708.8K +— (+0.0%) | 6.28M +326.3K (+5.5%) | 0.64% -0.003 pp | 0.03% +0.000 pp | USD5.12 +73.0% | 3 qtrs — |
| 37 | ARROWMARK COLORADO HOLDINGS LLC | 708.4K +— (+0.0%) | 6.28M +325.9K (+5.5%) | 0.64% -0.003 pp | 0.14% +0.028 pp | USD9.90 -10.5% | 9 qtrs — |
| 38 | BESSEMER GROUP INC | 708.4K +— (+0.0%) | 6.28M +325.0K (+5.5%) | 0.64% -0.003 pp | 0.01% +0.001 pp | USD4.53 +95.6% | 15 qtrs — |
| 39 | BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 653.5K -2.1M (-75.9%) | 5.79M -17.0M (-74.6%) | 0.59% -1.865 pp | 0.44% -1.069 pp | USD12.37 -28.4% | 18 qtrs — |
| 40 | MILLENNIUM MANAGEMENT LLC | 593.0K -702.4K (-54.2%) | 5.25M -5.6M (-51.7%) | 0.53% -0.638 pp | 0.00% -0.002 pp | USD2.25 +293.8% | 16 qtrs — |
| 41 | SPHERA FUNDS MANAGEMENT LTD. | 544.6K +544.6K (+100.0%) | 4.82M +4.8M (+100.0%) | 0.49% +0.491 pp | 0.93% +0.933 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 42 | PERCEPTIVE ADVISORS LLC | 513.0K +513.0K (+100.0%) | 4.55M +4.5M (+100.0%) | 0.46% +0.462 pp | 0.08% +0.081 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 43 | DIMENSIONAL FUND ADVISORS LP | 487.1K -185.7K (-27.6%) | 4.32M -1.3M (-23.6%) | 0.44% -0.170 pp | 0.00% 0.000 pp | USD6.61 +34.0% | 10 qtrs — |
| 44 | BANK OF AMERICA CORP /DE/ | 478.1K +322.6K (+207.5%) | 4.24M +2.9M (+224.4%) | 0.43% +0.290 pp | 0.00% +0.000 pp | USD8.39 +5.6% | 17 qtrs — |
| 45 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 446.2K -3.1M (-87.3%) | 3.95M -25.7M (-86.7%) | 0.40% -2.788 pp | 0.00% -0.016 pp | USD7.94 +11.6% | 9 qtrs — |
| 46 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 386.9K +386.9K (+100.0%) | 3.43M +3.4M (+100.0%) | 0.35% +0.349 pp | 0.18% +0.176 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 47 | BARCLAYS PLC | 368.2K +241.9K (+191.6%) | 3.26M +2.3M (+235.5%) | 0.33% +0.218 pp | 0.00% +0.001 pp | USD8.13 +9.0% | 16 qtrs — |
| 48 | BANK OF NEW YORK MELLON CORP | 343.8K +151.5K (+78.8%) | 3.05M +1.4M (+88.5%) | 0.31% +0.136 pp | 0.00% +0.000 pp | USD7.15 +23.9% | 18 qtrs — |
| 49 | MARSHALL WACE, LLP | 329.2K -1.2M (-77.9%) | 2.92M -9.6M (-76.7%) | 0.30% -1.051 pp | 0.00% -0.010 pp | USD1.37 +546.7% | 8 qtrs — |
| 50 | QUBE RESEARCH & TECHNOLOGIES LTD | 318.7K +318.7K (+100.0%) | 2.82M +2.8M (+100.0%) | 0.29% +0.287 pp | 0.00% +0.003 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 51 | NUVEEN, LLC | 300.4K -627.6K (-67.6%) | 2.66M -5.1M (-65.9%) | 0.27% -0.569 pp | 0.00% -0.001 pp | USD6.02 +47.2% | 4 qtrs — |
| 52 | GREAT LAKES ADVISORS, LLC | 294.3K -129.5K (-30.6%) | 2.61M -952.8K (-26.8%) | 0.27% -0.118 pp | 0.02% -0.009 pp | USD8.40 +5.5% | 2 qtrs — |
| 53 | ACUTA CAPITAL PARTNERS, LLC | 282.7K +282.7K (+100.0%) | 2.51M +2.5M (+100.0%) | 0.25% +0.255 pp | 1.70% +1.701 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 54 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 255.1K -129.1K (-33.6%) | 2.26M -966.9K (-30.0%) | 0.23% -0.118 pp | 0.01% -0.003 pp | USD8.40 +5.5% | 2 qtrs — |
| 55 | CONGRESS ASSET MANAGEMENT CO /MA | 234.6K +6.5K (+2.9%) | 2.08M +162.6K (+8.5%) | 0.21% +0.005 pp | 0.01% +0.002 pp | USD8.52 +4.0% | 7 qtrs — |
| 56 | WELLINGTON MANAGEMENT GROUP LLP | 233.9K -19.4K (-7.7%) | 2.07M -55.6K (-2.6%) | 0.21% -0.018 pp | 0.00% +0.000 pp | USD8.40 +5.5% | 2 qtrs — |
| 57 | RAFFERTY ASSET MANAGEMENT, LLC | 226.6K +81.3K (+55.9%) | 2.01M +787.0K (+64.5%) | 0.20% +0.073 pp | 0.01% +0.003 pp | USD8.57 +3.4% | 2 qtrs — |
| 58 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 200.0K +200.0K (+100.0%) | 1.77M +1.8M (+100.0%) | 0.18% +0.180 pp | 0.09% +0.088 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 59 | TRV GP VI, LLC | 194.2K +— (+0.0%) | 1.72M +89.3K (+5.5%) | 0.18% -0.001 pp | 1.16% -0.330 pp | USD3.09 +186.7% | 5 qtrs — |
| 60 | FISHER ASSET MANAGEMENT, LLC | 187.7K -22.7K (-10.8%) | 1.66M -104.0K (-5.9%) | 0.17% -0.021 pp | 0.00% 0.000 pp | USD7.05 +25.7% | 9 qtrs — |
| 61 | INVESCO LTD. | 177.6K -854.3K (-82.8%) | 1.57M -7.1M (-81.8%) | 0.16% -0.774 pp | 0.00% -0.001 pp | USD8.11 +9.2% | 15 qtrs — |
| 62 | SQUAREPOINT OPS LLC | 173.9K +173.9K (+100.0%) | 1.54M +1.5M (+100.0%) | 0.16% +0.157 pp | 0.00% +0.002 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 63 | CITADEL ADVISORS LLC | 151.9K +151.9K (+100.0%) | 1.35M +1.3M (+100.0%) | 0.14% +0.137 pp | 0.00% +0.000 pp | USD8.86 +0.0% | 18 qtrs — |
| 64 | TWO SIGMA INVESTMENTS, LP | 144.4K +— (+0.0%) | 1.28M +66.4K (+5.5%) | 0.13% -0.001 pp | 0.00% +0.000 pp | USD8.25 +7.4% | 12 qtrs — |
| 65 | ADAR1 CAPITAL MANAGEMENT, LLC | 140.0K +140.0K (+100.0%) | 1.24M +1.2M (+100.0%) | 0.13% +0.126 pp | 0.09% +0.091 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 66 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 129.5K +129.5K (+100.0%) | 1.15M +1.1M (+100.0%) | 0.12% +0.117 pp | 0.00% +0.003 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 67 | RHUMBLINE ADVISERS | 129.1K +21.3K (+19.7%) | 1.14M +238.0K (+26.3%) | 0.12% +0.019 pp | 0.00% +0.000 pp | USD5.43 +63.2% | 15 qtrs — |
| 68 | VERITION FUND MANAGEMENT LLC | 121.8K +97.0K (+392.0%) | 1.08M +871.1K (+418.9%) | 0.11% +0.087 pp | 0.00% +0.003 pp | USD8.77 +1.0% | 2 qtrs — |
| 69 | WELLS FARGO & COMPANY/MN | 121.2K +66.2K (+120.3%) | 1.07M +611.7K (+132.4%) | 0.11% +0.059 pp | 0.00% +0.000 pp | USD7.19 +23.2% | 12 qtrs — |
| 70 | GSA CAPITAL PARTNERS LLP | 118.6K +118.6K (+100.0%) | 1.05M +1.1M (+100.0%) | 0.11% +0.107 pp | 0.09% +0.091 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 71 | ALLIANCEBERNSTEIN L.P. | 106.5K +4.2K (+4.1%) | 943.5K +84.4K (+9.8%) | 0.10% +0.003 pp | 0.00% +0.000 pp | USD6.51 +36.1% | 13 qtrs — |
| 72 | TREXQUANT INVESTMENT LP | 105.3K -93.8K (-47.1%) | 932.7K -739.6K (-44.2%) | 0.09% -0.085 pp | 0.01% -0.009 pp | USD8.40 +5.5% | 2 qtrs — |
| 73 | SWISS NATIONAL BANK | 87.8K +87.8K (+100.0%) | 777.9K +777.9K (+100.0%) | 0.08% +0.079 pp | 0.00% +0.001 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 74 | PROFUND ADVISORS LLC | 83.8K +52.5K (+167.7%) | 742.1K +479.3K (+182.4%) | 0.08% +0.047 pp | 0.02% +0.014 pp | USD8.69 +2.0% | 2 qtrs — |
| 75 | AQR CAPITAL MANAGEMENT LLC | 82.2K +3.1K (+3.9%) | 728.6K +63.5K (+9.6%) | 0.07% +0.003 pp | 0.00% +0.000 pp | USD1.67 +430.5% | 9 qtrs — |
| 76 | DEUTSCHE BANK AG\ | 74.2K +15.1K (+25.5%) | 657.4K +160.6K (+32.3%) | 0.07% +0.013 pp | 0.00% +0.000 pp | USD5.39 +64.4% | 15 qtrs — |
| 77 | TUDOR INVESTMENT CORP ET AL | 68.3K +14.7K (+27.4%) | 604.7K +154.7K (+34.4%) | 0.06% +0.013 pp | 0.00% +0.000 pp | USD8.50 +4.2% | 9 qtrs — |
| 78 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 62.6K +22.2K (+55.0%) | 551.9K +212.3K (+62.5%) | 0.06% +0.020 pp | 0.00% +0.000 pp | USD7.92 +11.9% | 7 qtrs — |
| 79 | METLIFE INVESTMENT MANAGEMENT, LLC | 59.7K +12.0K (+25.1%) | 528.9K +128.0K (+31.9%) | 0.05% +0.011 pp | 0.00% +0.001 pp | USD5.87 +50.9% | 15 qtrs — |
| 80 | Y-INTERCEPT (HONG KONG) LTD | 59.3K +22.4K (+60.5%) | 525.7K +215.2K (+69.3%) | 0.05% +0.020 pp | 0.01% +0.004 pp | USD8.57 +3.4% | 2 qtrs — |
| 81 | PRICE T ROWE ASSOCIATES INC /MD/ | 58.4K +17.8K (+43.7%) | 518.0K +175.0K (+51.0%) | 0.05% +0.016 pp | 0.00% +0.000 pp | USD7.57 +17.0% | 10 qtrs — |
| 82 | LOS ANGELES CAPITAL MANAGEMENT LLC | 64.2K +47.1K (+273.8%) | 512.0K +367.7K (+254.7%) | 0.06% +0.042 pp | 0.00% +0.001 pp | USD7.76 +14.2% | 5 qtrs — |
| 83 | JPMORGAN CHASE & CO | 56.8K +22.9K (+67.6%) | 503.6K +218.7K (+76.8%) | 0.05% +0.021 pp | 0.00% +0.000 pp | USD7.37 +20.2% | 18 qtrs — |
| 84 | DEKABANK DEUTSCHE GIROZENTRALE | 60.0K +— (+0.0%) | 502.0K +5.0K (+1.0%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD11.26 -21.3% | 10 qtrs — |
| 85 | SEI INVESTMENTS CO | 53.9K +43.9K (+436.9%) | 477.8K +393.4K (+466.2%) | 0.05% +0.040 pp | 0.00% +0.000 pp | USD8.77 +1.0% | 4 qtrs — |
| 86 | GRAHAM CAPITAL MANAGEMENT, L.P. | 51.3K +51.3K (+100.0%) | 454.7K +454.7K (+100.0%) | 0.05% +0.046 pp | 0.01% +0.011 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 87 | CANADA PENSION PLAN INVESTMENT BOARD | 50.4K +50.4K (+100.0%) | 446.5K +446.5K (+100.0%) | 0.05% +0.045 pp | 0.00% +0.000 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 88 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 48.2K +43.4K (+906.9%) | 427.1K +386.9K (+962.0%) | 0.04% +0.039 pp | 0.00% +0.000 pp | USD8.70 +1.8% | 17 qtrs — |
| 89 | VOYA INVESTMENT MANAGEMENT LLC | 47.8K +34.3K (+255.1%) | 423.6K +310.5K (+274.5%) | 0.04% +0.031 pp | 0.00% +0.000 pp | USD7.79 +13.7% | 15 qtrs — |
| 90 | — | 46.1K +46.1K (+100.0%) | 408.7K +408.7K (+100.0%) | 0.04% +0.042 pp | 0.14% +0.142 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 91 | CREATIVE PLANNING | 41.9K +6.7K (+18.9%) | 371.3K +75.2K (+25.4%) | 0.04% +0.006 pp | 0.00% +0.000 pp | USD8.47 +4.6% | 2 qtrs — |
| 92 | UBS ASSET MANAGEMENT AMERICAS INC | 41.5K +41.5K (+100.0%) | 367.3K +367.3K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.000 pp | USD8.86 +0.0% | 1 qtrs NEW |
| 93 | LEGAL & GENERAL GROUP PLC | 39.4K +33.0K (+511.8%) | 349.4K +295.2K (+545.3%) | 0.04% +0.030 pp | 0.00% +0.000 pp | USD8.30 +6.7% | 17 qtrs — |
| 94 | INTECH INVESTMENT MANAGEMENT LLC | 38.9K +10.8K (+38.3%) | 345.0K +108.5K (+45.9%) | 0.04% +0.010 pp | 0.00% +0.001 pp | USD6.57 +34.9% | 6 qtrs — |
| 95 | XTX TOPCO LTD | 37.8K +37.8K (+100.0%) | 335.2K +335.2K (+100.0%) | 0.03% +0.034 pp | 0.01% +0.009 pp | USD8.86 +0.0% | 8 qtrs — |
| 96 | CITIGROUP INC | 36.2K +18.1K (+100.2%) | 321.1K +169.0K (+111.1%) | 0.03% +0.016 pp | 0.00% +0.000 pp | USD7.88 +12.4% | 18 qtrs — |
| 97 | JANNEY MONTGOMERY SCOTT LLC | 36.0K +— (+0.0%) | 319.0K +17.0K (+5.6%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD4.53 +95.6% | 18 qtrs — |
| 98 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 35.2K -53.6K (-60.4%) | 312.0K -434.2K (-58.2%) | 0.03% -0.049 pp | 0.00% +0.000 pp | USD4.55 +94.7% | 17 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
0.63
Neutral
Buys
4
Sells
4
Shares acquired
83.0K
Shares disposed
130.9K
Cash buys
—
Cash sales
2.00
Net activity
-47,960
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Gall Matthew | Officer | A-Award | A | Stock Option (Right to Buy) | 240,000 | 20.98 | 5.04M | 240,000 | D | ↗ |
| 2026-05-01 | Crystal Adam | Officer | M-Exempt | D | Stock Option (Right to Buy) | 27,000 | 5.20 | 140.4K | 368,040 | D | ↗ |
| 2026-04-29 | Lee Sung | Director | A-Award | A | Common Stock | 12,300 | 0.00 | — | 22,300 | D | ↗ |
| 2026-04-15 | Newcomb Jessica | Officer | — | — | Stock Option (Right to Buy) | 10,000 | 3.13 | 31.3K | 0 | D | ↗ |
| 2026-04-15 | Gall Matthew | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-04-15 | Crystal Adam | Officer | S-Sale | D | Common Stock | 38,460 | 25.00 | 961.5K | 112,622 | D | ↗ |
| 2026-04-01 | Crystal Adam | Officer | M-Exempt | D | Stock Option (Right to Buy) | 27,000 | 5.20 | 140.4K | 433,500 | D | ↗ |
| 2026-03-25 | Crystal Adam | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,000 | 5.20 | 62.4K | 460,500 | D | ↗ |
| 2026-03-05 | Crystal Adam | Officer | S-Sale | D | Common Stock | 20,251 | 15.00 | 303.8K | 112,622 | D | ↗ |
| 2026-02-25 | Crystal Adam | Officer | S-Sale | D | Common Stock | 54,345 | 12.77 | 694.2K | 132,873 | D | ↗ |
| 2026-02-03 | Weber Barbara | Director / Officer | S-Sale | D | Common Stock | 30,186 | 12.26 | 370.0K | 1,629,587 | D | ↗ |
| 2026-02-03 | Crystal Adam | Officer | S-Sale | D | Common Stock | 18,251 | 12.26 | 223.7K | 187,419 | D | ↗ |
| 2026-02-03 | Beckman Daniella | Officer | S-Sale | D | Common Stock | 10,204 | 12.26 | 125.1K | 184,410 | D | ↗ |
| 2026-02-02 | Weber Barbara | Director / Officer | A-Award | A | Common Stock | 37,522 | 0.00 | — | 1,659,773 | D | ↗ |
| 2026-02-02 | Crystal Adam | Officer | A-Award | A | Stock Option (Right to Buy) | 284,760 | 11.94 | 3.40M | 284,760 | D | ↗ |
| 2026-02-02 | Beckman Daniella | Officer | A-Award | A | Common Stock | 44,330 | 0.00 | — | 194,614 | D | ↗ |
| 2026-01-08 | Peters Malte | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,650,000 | 11.06 | 18.25M | 1,650,000 | D | ↗ |
| 2026-01-02 | Lee Sung | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 10,000 | D | ↗ |
| 2025-11-03 | Peters Malte | Director | A-Award | A | Stock Option (Right to Buy) | 150,000 | 8.01 | 1.20M | 150,000 | D | ↗ |
| 2025-10-23 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 477,401 | 10.15 | 4.85M | 13,386,574 | D | ↗ |
| 2025-09-25 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 500,000 | 8.02 | 4.01M | 13,863,975 | D | ↗ |
| 2025-09-16 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 363,541 | 7.04 | 2.56M | 14,363,975 | D | ↗ |
| 2025-09-08 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 86,459 | 7.04 | 608.6K | 14,727,516 | D | ↗ |
| 2025-09-05 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 642,906 | 7.00 | 4.50M | 14,813,975 | D | ↗ |
| 2025-08-22 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 302,194 | 7.00 | 2.12M | 15,456,881 | D | ↗ |
| 2025-08-19 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 1,100,000 | 7.01 | 7.71M | 15,759,075 | D | ↗ |
| 2025-06-05 | Rothenberg Mace | Director | A-Award | A | Stock Option (Right to Buy) | 37,500 | 3.51 | 131.6K | 37,500 | D | ↗ |
| 2025-06-05 | Peters Malte | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 17,500 | D | ↗ |
| 2025-06-05 | Ketchum John B | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 20,937 | D | ↗ |
| 2025-06-05 | Calhoun Lesley Ann | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 12,500 | D | ↗ |
| 2025-06-05 | Borisy Alexis | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 17,500 | D | ↗ |
| 2025-02-05 | Weber Barbara | Director / Officer | S-Sale | D | Common Stock | 9,013 | 3.16 | 28.5K | 1,622,251 | D | ↗ |
| 2025-02-05 | Crystal Adam | Officer | S-Sale | D | Common Stock | 6,851 | 3.16 | 21.7K | 158,210 | D | ↗ |
| 2025-02-05 | Beckman Daniella | Officer | S-Sale | D | Common Stock | 3,948 | 3.16 | 12.5K | 150,284 | D | ↗ |
| 2025-02-05 | Barry Douglas | Officer | S-Sale | D | Common Stock | 2,556 | 3.16 | 8.1K | 66,014 | D | ↗ |
| 2025-02-04 | Weber Barbara | Director / Officer | S-Sale | D | Common Stock | 9,778 | 2.99 | 29.2K | 1,631,264 | D | ↗ |
| 2025-02-04 | Crystal Adam | Officer | S-Sale | D | Common Stock | 7,432 | 2.99 | 22.2K | 165,061 | D | ↗ |
| 2025-02-04 | Beckman Daniella | Officer | S-Sale | D | Common Stock | 4,284 | 2.99 | 12.8K | 154,232 | D | ↗ |
| 2025-02-04 | Barry Douglas | Officer | S-Sale | D | Common Stock | 2,774 | 2.99 | 8.3K | 68,570 | D | ↗ |
| 2025-02-03 | Weber Barbara | Director / Officer | A-Award | A | Common Stock | 105,875 | 0.00 | — | 1,641,042 | D | ↗ |
| 2025-02-03 | Crystal Adam | Officer | A-Award | A | Common Stock | 53,015 | 0.00 | — | 172,493 | D | ↗ |
| 2025-02-03 | Beckman Daniella | Officer | A-Award | A | Stock Option (Right to Buy) | 156,713 | 2.91 | 456.0K | 156,713 | D | ↗ |
| 2025-02-03 | Barry Douglas | Officer | A-Award | A | Common Stock | 27,363 | 0.00 | — | 71,344 | D | ↗ |
| 2024-11-18 | Rothenberg Mace | Director | P-Purchase | A | Common Stock | 10,000 | 3.78 | 37.8K | 31,250 | D | ↗ |
| 2024-11-14 | Rothenberg Mace | Director | P-Purchase | A | Common Stock | 10,000 | 3.62 | 36.2K | 21,250 | D | ↗ |
| 2024-11-07 | EcoR1 Capital, LLC | 10% Owner | S-Sale | D | Common Stock | 62,318 | 3.29 | 205.1K | 11,773,860 | I | ↗ |
| 2024-11-06 | EcoR1 Capital, LLC | 10% Owner | S-Sale | D | Common Stock | 1,494,558 | 3.28 | 4.90M | 11,836,178 | I | ↗ |
| 2024-11-06 | Boxer Capital Management, LLC | Other | S-Sale | D | Common Stock | 3,080,000 | 3.14 | 9.67M | 3,610,642 | I | ↗ |
| 2024-10-25 | Boxer Capital Management, LLC | Other | S-Sale | D | Common Stock | 633,000 | 6.87 | 4.35M | 6,690,642 | D | ↗ |
| 2024-10-22 | Boxer Capital Management, LLC | Other | S-Sale | D | Common Stock | 250,000 | 6.78 | 1.70M | 7,323,642 | D | ↗ |
| 2024-10-21 | Boxer Capital Management, LLC | Other | S-Sale | D | Common Stock | 625,000 | 7.05 | 4.41M | 7,573,642 | D | ↗ |
| 2024-10-10 | Boxer Capital Management, LLC | Other | — | — | Common Stock | 0 | 0.00 | — | 8,198,642 | I | ↗ |
| 2024-09-13 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 67,400 | 10.53 | 709.8K | 16,859,075 | — | ↗ |
| 2024-09-05 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 75,000 | 11.56 | 867.1K | 16,926,475 | — | ↗ |
| 2024-09-03 | Davis Aaron I. | Other | J-Other | A | Stock Option (Right to Buy) | 65,000 | 10.93 | 710.5K | 65,000 | — | ↗ |
| 2024-08-30 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 175,000 | 11.60 | 2.03M | 17,001,475 | — | ↗ |
| 2024-08-27 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 25,000 | 11.55 | 288.7K | 17,176,475 | — | ↗ |
| 2024-08-19 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 150,000 | 10.09 | 1.51M | 17,201,475 | — | ↗ |
| 2024-08-16 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 135,000 | 9.79 | 1.32M | 17,351,475 | — | ↗ |
| 2024-08-01 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 40,000 | 9.80 | 392.0K | 17,486,475 | — | ↗ |
| 2024-07-31 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 100,000 | 9.93 | 993.4K | 17,526,475 | — | ↗ |
| 2024-07-30 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 95,000 | 9.80 | 931.1K | 17,626,475 | — | ↗ |
| 2024-07-26 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.84 | 492.0K | 17,721,475 | — | ↗ |
| 2024-07-25 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 100,599 | 9.87 | 992.8K | 17,771,475 | — | ↗ |
| 2024-07-24 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 200,000 | 9.82 | 1.96M | 17,872,074 | — | ↗ |
| 2024-07-23 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 125,000 | 9.79 | 1.22M | 18,072,074 | — | ↗ |
| 2024-07-22 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 262,740 | 9.78 | 2.57M | 18,197,074 | — | ↗ |
| 2024-07-18 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 191,490 | 9.81 | 1.88M | 18,459,814 | — | ↗ |
| 2024-07-17 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 550,171 | 9.79 | 5.39M | 18,651,304 | — | ↗ |
| 2024-07-02 | MVA Investors, LLC | Other | S-Sale | D | Common Stock | 95,000 | 8.68 | 824.6K | 108,793 | — | ↗ |
| 2024-07-01 | MVA Investors, LLC | Other | S-Sale | D | Common Stock | 110,731 | 8.87 | 982.2K | 203,793 | — | ↗ |
| 2024-06-28 | MVA Investors, LLC | Other | S-Sale | D | Common Stock | 29,000 | 8.57 | 248.5K | 314,524 | — | ↗ |
| 2024-06-07 | MVA Investors, LLC | Other | S-Sale | D | Common Stock | 77,000 | 6.88 | 529.8K | 343,524 | — | ↗ |
| 2024-06-06 | MVA Investors, LLC | Other | S-Sale | D | Common Stock | 63,000 | 7.24 | 456.1K | 420,524 | — | ↗ |
| 2024-06-05 | Rothenberg Mace | Director | A-Award | A | Stock Option (Right to Buy) | 37,500 | 7.41 | 277.9K | 37,500 | — | ↗ |
| 2024-06-05 | Peters Malte | Director | A-Award | A | Stock Option (Right to Buy) | 37,500 | 7.41 | 277.9K | 37,500 | — | ↗ |
| 2024-06-05 | Ketchum John B | Director | A-Award | A | Stock Option (Right to Buy) | 28,125 | 7.41 | 208.4K | 28,125 | — | ↗ |
| 2024-06-05 | Calhoun Lesley Ann | Director | A-Award | A | Stock Option (Right to Buy) | 37,500 | 7.41 | 277.9K | 37,500 | — | ↗ |
| 2024-06-05 | Borisy Alexis | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 11,250 | — | ↗ |
| 2024-05-03 | MVA Investors, LLC | Other | S-Sale | D | Common Stock | 60,000 | 7.61 | 456.6K | 483,524 | — | ↗ |
| 2024-05-02 | MVA Investors, LLC | Other | S-Sale | D | Common Stock | 75,000 | 7.56 | 567.0K | 543,524 | — | ↗ |
| 2024-05-01 | MVA Investors, LLC | Other | S-Sale | D | Common Stock | 75,000 | 7.43 | 557.3K | 618,524 | — | ↗ |
| 2024-02-20 | Third Rock Ventures IV, L.P. | 10% Owner | S-Sale | D | Common Stock | 162,500 | 12.00 | 1.95M | 19,201,475 | — | ↗ |
| 2024-02-07 | Weber Barbara | Director / Officer | S-Sale | D | Common Stock | 4,457 | 12.62 | 56.2K | 1,535,167 | — | ↗ |
| 2024-02-07 | Crystal Adam | Officer | S-Sale | D | Common Stock | 4,083 | 12.62 | 51.5K | 119,478 | — | ↗ |
| 2024-02-07 | Beckman Daniella | Officer | S-Sale | D | Common Stock | 1,817 | 12.62 | 22.9K | 132,397 | — | ↗ |
| 2024-02-07 | Barry Douglas | Officer | S-Sale | D | Common Stock | 1,354 | 12.62 | 17.1K | 43,981 | — | ↗ |
| 2024-02-06 | Weber Barbara | Director / Officer | S-Sale | D | Common Stock | 4,681 | 12.56 | 58.8K | 1,539,624 | — | ↗ |
| 2024-02-06 | Crystal Adam | Officer | S-Sale | D | Common Stock | 4,288 | 12.56 | 53.9K | 123,561 | — | ↗ |
| 2024-02-06 | Beckman Daniella | Officer | S-Sale | D | Common Stock | 1,908 | 12.56 | 24.0K | 134,214 | — | ↗ |
| 2024-02-06 | Barry Douglas | Officer | S-Sale | D | Common Stock | 1,422 | 12.56 | 17.9K | 45,335 | — | ↗ |
| 2024-02-01 | Weber Barbara | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 523,012 | 12.28 | 6.42M | 523,012 | — | ↗ |
| 2024-02-01 | Crystal Adam | Officer | A-Award | A | Common Stock | 46,599 | 0.00 | — | 46,599 | — | ↗ |
| 2024-02-01 | Beckman Daniella | Officer | A-Award | A | Common Stock | 39,413 | 0.00 | — | 39,413 | — | ↗ |
| 2024-02-01 | Barry Douglas | Officer | A-Award | A | Common Stock | 22,859 | 0.00 | — | 22,859 | — | ↗ |
| 2023-11-06 | Pothula Kanishka | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-11-01 | Crystal Adam | Officer | S-Sale | D | Common Stock | 7,507 | 8.39 | 63.0K | 81,250 | — | ↗ |
| 2023-10-16 | Boxer Capital, LLC | Other | P-Purchase | A | Common Stock | 500,000 | 6.84 | 3.42M | 8,198,642 | D | ↗ |
| 2023-10-13 | EcoR1 Capital, LLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 13,330,736 | — | ↗ |
| 2023-10-13 | Boxer Capital, LLC | Other | P-Purchase | A | Common Stock | 750,000 | 7.07 | 5.30M | 7,698,642 | D | ↗ |
| 2023-10-09 | Boxer Capital, LLC | — | S-Sale | D | Common Stock | 175,000 | 9.97 | 1.74M | 6,948,642 | — | ↗ |
| 2023-08-29 | Ketchum John B | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-11 | Third Rock Ventures VI, L.P. | Director | — | D | Common Stock | 0 | 0.00 | — | 194,174 | — | ↗ |
| 2023-08-11 | Boxer Capital, LLC | — | P-Purchase | A | Prefunded Warrant | 2,340,579 | 0.00 | — | 2,340,597 | — | ↗ |
| 2023-06-06 | Rothenberg Mace | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2023-06-06 | Peters Malte | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2023-06-06 | Huber Reid M | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2023-06-06 | Davis Aaron I. | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2023-06-06 | Calhoun Lesley Ann | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2023-06-06 | Borisy Alexis | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2023-03-01 | Weber Barbara | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 537,273 | 5.20 | 2.79M | 537,273 | — | ↗ |
| 2023-03-01 | Huang Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 190,181 | 5.20 | 988.9K | 190,181 | — | ↗ |
| 2023-03-01 | Crystal Adam | Officer | A-Award | A | Common Stock | 81,250 | 0.00 | — | 81,250 | — | ↗ |
| 2023-03-01 | Beckman Daniella | Officer | A-Award | A | Common Stock | 32,842 | 0.00 | — | 96,709 | — | ↗ |
| 2023-03-01 | Barry Douglas | Officer | A-Award | A | Common Stock | 23,898 | 0.00 | — | 23,898 | — | ↗ |
| 2023-02-27 | Crystal Adam | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-01 | Weitzman Aaron | Officer | A-Award | A | Stock Option (Right to Buy) | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2022-10-13 | Davis Aaron I. | Director | P-Purchase | A | Common Stock | 70,000 | 4.65 | 325.2K | 7,123,642 | — | ↗ |
| 2022-10-13 | Boxer Capital, LLC | 10% Owner | P-Purchase | A | Common Stock | 70,000 | 4.65 | 325.2K | 7,123,642 | — | ↗ |
| 2022-10-12 | Davis Aaron I. | Director | P-Purchase | A | Common Stock | 50,000 | 4.43 | 221.6K | 268,524 | — | ↗ |
| 2022-10-12 | Boxer Capital, LLC | 10% Owner | P-Purchase | A | Common Stock | 50,000 | 4.43 | 221.6K | 268,524 | — | ↗ |
| 2022-10-11 | Davis Aaron I. | Director | P-Purchase | A | Common Stock | 117,000 | 4.25 | 497.7K | 218,524 | — | ↗ |
| 2022-10-11 | Boxer Capital, LLC | 10% Owner | P-Purchase | A | Common Stock | 117,000 | 4.25 | 497.7K | 218,524 | — | ↗ |
| 2022-10-06 | LEWIS JOSEPH | Director | P-Purchase | A | Common Stock | 70,394 | 4.06 | 286.1K | 7,053,642 | — | ↗ |
| 2022-10-06 | Boxer Capital, LLC | 10% Owner | P-Purchase | A | Common Stock | 70,394 | 4.06 | 286.1K | 7,053,642 | — | ↗ |
| 2022-10-05 | LEWIS JOSEPH | Director | P-Purchase | A | Common Stock | 40,500 | 3.84 | 155.4K | 6,983,248 | — | ↗ |
| 2022-10-05 | Boxer Capital, LLC | 10% Owner | P-Purchase | A | Common Stock | 40,500 | 3.84 | 155.4K | 6,983,248 | — | ↗ |
| 2022-10-04 | LEWIS JOSEPH | Director | P-Purchase | A | Common Stock | 25,606 | 3.67 | 94.0K | 6,897,248 | — | ↗ |
| 2022-10-04 | Boxer Capital, LLC | 10% Owner | P-Purchase | A | Common Stock | 25,606 | 3.67 | 94.0K | 6,897,248 | — | ↗ |
| 2022-06-08 | Rothenberg Mace | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2022-06-08 | Peters Malte | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2022-06-08 | Huber Reid M | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2022-06-08 | Davis Aaron I. | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 5.90 | 236.0K | 40,000 | — | ↗ |
| 2022-06-08 | Calhoun Lesley Ann | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 5.90 | 236.0K | 40,000 | — | ↗ |
| 2022-06-08 | Borisy Alexis | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 5.90 | 236.0K | 40,000 | — | ↗ |
| 2022-02-01 | Weber Barbara | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 625,000 | 9.22 | 5.76M | 625,000 | — | ↗ |
| 2022-02-01 | Huang Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 9.22 | 1.84M | 200,000 | — | ↗ |
| 2022-02-01 | Beckman Daniella | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 9.22 | 1.38M | 150,000 | — | ↗ |
| 2022-02-01 | Barry Douglas | Officer | A-Award | A | Stock Option (Right to Buy) | 69,500 | 9.22 | 640.8K | 69,500 | — | ↗ |
| 2021-11-01 | Rudoltz Marc | Officer | A-Award | A | Stock Option (Right to Buy) | 350,000 | 12.91 | 4.52M | 350,000 | — | ↗ |
| 2021-10-18 | Rudoltz Marc | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-14 | Barry Douglas | Officer | — | D | Stock Option (Right to Buy) | 246,296 | 9.56 | 2.35M | 0 | — | ↗ |
| 2021-08-12 | Weber Barbara | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 961,403 | 9.56 | 9.19M | 961,403 | — | ↗ |
| 2021-08-12 | Huang Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 169,859 | 9.56 | 1.62M | 169,859 | — | ↗ |
| 2021-08-12 | Beckman Daniella | Officer | A-Award | A | Stock Option (Right to Buy) | 380,485 | 9.56 | 3.64M | 380,485 | — | ↗ |
| 2021-08-10 | Weber Barbara | Director / Officer | — | D | Stock Option (Right to Buy) | 219,164 | 1.65 | 361.2K | 0 | — | ↗ |
| 2021-08-10 | Third Rock Ventures IV, L.P. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 19,363,975 | — | ↗ |
| 2021-08-10 | Rothenberg Mace | Director | — | D | Stock Option (Right to Buy) | 84,929 | 7.57 | 642.5K | 0 | — | ↗ |
| 2021-08-10 | Peters Malte | Director | — | D | Stock Option (Right to Buy) | 118,901 | 1.38 | 164.4K | 0 | — | ↗ |
| 2021-08-10 | Huber Reid M | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-08-10 | Huang Alan | Officer | — | D | Stock Option (Right to Buy) | 67,944 | 3.50 | 238.0K | 0 | — | ↗ |
| 2021-08-10 | Calhoun Lesley Ann | Director | — | D | Stock Option (Right to Buy) | 84,929 | 7.57 | 642.5K | 0 | — | ↗ |
| 2021-08-10 | Braslyn Ltd. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 26,961 | — | ↗ |
| 2021-08-10 | Boxer Capital, LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 101,524 | — | ↗ |
| 2021-08-10 | Borisy Alexis | Director | — | D | Stock Option (Right to Buy) | 131,471 | 1.53 | 201.3K | 0 | — | ↗ |
| 2021-08-10 | Beckman Daniella | Officer | — | D | Stock Option (Right to Buy) | 165,443 | 1.53 | 253.3K | 0 | — | ↗ |
| 2021-08-10 | BCTG Holdings, LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 6,988,450 | — | ↗ |
| 2020-11-20 | BCTG Holdings, LLC | 10% Owner | S-Sale | D | Common Stock | 2,500 | 0.01 | 15.00 | 4,490,950 | — | ↗ |
| 2020-10-06 | Avery James B | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-09-08 | BCTG Holdings, LLC | 10% Owner | P-Purchase | A | Common Stock | 533,500 | 10.00 | 5.34M | 4,493,450 | — | ↗ |
| 2020-09-02 | Nuechterlein Carole | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-09-02 | Heyman Richard A. | Director | — | D | Common Stock | 0 | 0.00 | — | 40,600 | — | ↗ |
| 2020-09-02 | Fuglesang Christopher | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-09-02 | Ellis Andrew Ruel | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-09-02 | Davis Aaron I. | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-09-02 | Christensen Jamie | Director | — | D | Common Stock | 0 | 0.00 | — | 40,600 | — | ↗ |
| 2020-09-02 | Beauchamp Michael | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-09-02 | BCTG Holdings, LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,959,950 | — | ↗ |
| 2020-09-02 | BAUM CHARLES M | Director | — | D | Common Stock | 0 | 0.00 | — | 40,600 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-718.0K
Shares Outstanding
116.17M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Barbara Weber, M.D. Executive Chairman | 698.0K | — | 308.1K | 1.28M | 524.3K | 18.4K | 2.82M | 56.07% | ↗ |
| 2 | 2025 | Adam Crystal, M.D., Ph.D. President of Research and Development | 588.6K | — | 154.3K | 638.6K | 321.5K | 18.1K | 1.72M | 46.07% | ↗ |
| 3 | 2025 | Daniella Beckman Former Chief Financial Officer | 502.9K | — | 76.0K | 314.6K | 244.1K | 18.2K | 1.16M | 33.80% | ↗ |
| 4 | 2024 | Barbara Weber, M.D. President, Chief Executive Officer and Director | 660.0K | — | 1.07M | 4.35M | 447.5K | 18.0K | 6.54M | 82.79% | ↗ |
| 5 | 2024 | Barbara Weber, M.D. Executive Chairman | 660.0K | — | 1.07M | 4.35M | 447.5K | 18.0K | 6.54M | 82.79% | ↗ |
| 6 | 2024 | Adam Crystal, M.D., Ph.D. President of Research and Development | 569.3K | — | 572.2K | 2.32M | 297.1K | 15.8K | 3.78M | 76.65% | ↗ |
| 7 | 2024 | Daniella Beckman Former Chief Financial Officer | 486.3K | — | 484.0K | 1.96M | 213.5K | 17.8K | 3.17M | 77.34% | ↗ |
| 8 | 2024 | Daniella Beckman Chief Financial Officer | 486.3K | — | 484.0K | 1.96M | 213.5K | 17.8K | 3.17M | 77.34% | ↗ |
| 9 | 2024 | Douglas Barry Chief Legal Officer | 451.2K | — | 280.7K | 1.14M | 204.8K | 18.2K | 2.09M | 67.81% | ↗ |
| 10 | 2023 | Barbara Weber, M.D. President, Chief Executive Officer and Director | 626.0K | — | 465.6K | 1.89M | 396.6K | 17.2K | 3.39M | 69.34% | ↗ |
| 11 | 2023 | Barbara Weber, M.D. Executive Chairman | 626.0K | — | 465.6K | 1.89M | 396.6K | 17.2K | 3.39M | 69.34% | ↗ |
| 12 | 2023 | Adam Crystal, M.D., Ph.D. President of Research and Development | 454.8K | 275.0K | 422.5K | 1.71M | 242.8K | 4.6K | 3.11M | 68.58% | ↗ |
| 13 | 2023 | Alan Huang, Ph.D. Former Chief Scientific Officer | 350.6K | — | 197.8K | 807.0K | 330.0K | 85.4K | 1.77M | 56.74% | ↗ |
| 14 | 2023 | Daniella Beckman Chief Financial Officer | 441.8K | — | 170.8K | 691.6K | 210.0K | 8.6K | 1.52M | 56.63% | ↗ |
| 15 | 2023 | Daniella Beckman Former Chief Financial Officer | 441.8K | — | 170.8K | 691.6K | 210.0K | 8.6K | 1.52M | 56.63% | ↗ |
| 16 | 2022 | Barbara Weber, M.D. President, Chief Executive Officer and Director | 575.0K | — | — | 3.74M | 363.7K | 2.5K | 4.68M | 79.90% | ↗ |
| 17 | 2022 | Alan Huang, Ph.D. Former Chief Scientific Officer | 425.4K | — | — | 1.20M | 193.6K | 3.0K | 1.82M | 65.81% | ↗ |
| 18 | 2022 | Alan Huang, Ph.D. Chief Scientific Officer | 425.4K | — | — | 1.20M | 193.6K | 3.0K | 1.82M | 65.81% | ↗ |
| 19 | 2022 | Daniella Beckman Chief Financial Officer | 425.1K | — | — | 897.8K | 191.6K | 2.4K | 1.52M | 59.18% | ↗ |
| 20 | 2021 | Barbara Weber, M.D. President, Chief Executive Officer and Director | 513.7K | — | — | 10.72M | 277.9K | 4.6K | 11.52M | 93.09% | ↗ |
| 21 | 2021 | Daniella Beckman Chief Financial Officer | 377.9K | — | — | 2.63M | 164.6K | 3.3K | 3.18M | 82.82% | ↗ |
| 22 | 2021 | Alan Huang, Ph.D. Chief Scientific Officer | 394.8K | — | — | 1.65M | 168.3K | 3.4K | 2.22M | 74.43% | ↗ |
| 23 | 2020 | Barbara Weber, M.D. President, Chief Executive Officer and Director | 491.6K | — | — | 227.6K | 226.2K | 12.8K | 958.2K | 23.75% | ↗ |
| 24 | 2020 | Daniella Beckman Chief Financial Officer | 323.4K | — | — | 368.3K | 131.8K | 10.8K | 834.4K | 44.14% | ↗ |
| 25 | 2020 | Alan Huang, Ph.D. Chief Scientific Officer | 373.8K | — | — | 70.6K | 135.8K | 9.4K | 589.5K | 11.97% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Barbara L. Weber | Founder & Executive Chair | 1M | — |
| Adam S. Crystal | President of Research & Development | 928.2K | — |
| Matthew Gall | Chief Financial Officer | 717.6K | male |
| Daniella Beckman | Chief Financial Officer | 717.6K | female |
| Malte Peters | President, Chief Executive Officer & Director | 148.3K | — |
| Julie Carretero | Chief Human Resources Officer | — | female |
| Julie Fogarty | Vice President of Legal & Corporate Secretary | — | female |
| Michael Palmieri | Chief Technical Operations Officer | — | — |
| Philippe Serrano | Chief Regulatory Officer | — | — |
| William G. Kaelin Jr. | Founder & Member of Scientific Advisory Board | — | — |
| Alan Ashworth | Founder & Member of Scientific Advisory Board | — | — |
| Antoni Ribas | Founder & Member of Scientific Advisory Board | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TNGX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
